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A new labeling method compatible with both laser-induced fluorescence (LIF) and MS
detection for enkephalins, which uses naphthalene-2,3-dicarboxaldehyde (NDA) and a new
nucleophilic agent (N,N-dimethylaminoethanethiol) is described. When the derivative is
separated via reverse phase HPLC and detected via MS, two different peaks with similar exact
mass but different fluorescence and fragmentation properties are obtained. To interpret these
results, molecular modeling and H/D exchange mass spectrometry studies were investigated to
test the hypothesis that the peak obtained by LC/LIF/MS analysis depends on the site of
protonation of the labeled enkephalins. The peptides labeled with NDA and N,N-
dimethylaminoethanethiol were separated on a reverse phase C18 column with a gradient
of aqueous 0.1% formic acid and acetonitrile. In mass spectrometry, two peaks are
observed with the same exact mass for each molecule while only one peak is detected using
fluorescence. Tandem mass spectrometry experiments of ion m/z 809.5 were performed on
each chromatographic peak; the first peak (which is not observed by LIF detection) gives
a fragment corresponding to the loss of the aminothiol side chain while no fragmentation
is observed on the second peak, which was detected by fluorescence. The hypothesis is that
each peak represents the labeled enkephalin with different sites of protonation. According
to this hypothesis, three fundamental conformations that were closed to the unlabeled
leucine-enkephalin were obtained by molecular modeling: a -turn like conformation with two
hydrogen bonds, a 310-helix with an H bond, and finally, the extended form without any
intramolecular interactions. H/D exchange mass spectrometry experiments with D2O and d2-
formic acid as eluent was used to determine which conformation is involved in each peak. (J Am
Soc Mass Spectrom 2007, 18, 1706–1713) © 2007 American Society for Mass SpectrometryEnkephalins are opioid peptides discovered byHughes et al. in 1975 [1] with analgesic propertiessimilar to that of morphine. The two enkephalins,
leucine enkephalin (Leu-Enk) and methionine-enkephalin
(Met-Enk)arepentapeptides,whichdifferat theC-terminal
function (Tyr-Gly-Gly-Phe-Leu or Met) and act as neuro-
transmitters and neuromodulators [2]. These compounds
exert a profound influence on many physiological and
pathological states such as pain transmission, addiction,
and dementia [2– 4]. Opioid peptide levels are typically
measured by radioimmunoassay (RIA), enzyme-linked
immunoassay (ELISA), or radioreceptorassay (RRA) [5,
6]. However, these modes of quantitation require a
large sample volume and are reported to be less sensi-
tive than chromatographic methods coupled with elec-
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doi:10.1016/j.jasms.2007.07.007trochemical detection [7]. The two most common meth-
ods for quantitation are capillary electrophoresis (CE)
and high-performance liquid chromatography (HPLC)
[8] coupled to electrochemical detectors [7], UV detec-
tors [9], laser-induced fluorescence (LIF) detectors [10],
or mass spectrometry detection [11, 12].
Stobaugh et al. have developed chromatographicmeth-
ods to monitor leucine-enkephalin in biological samples
using fluorescence detection. These workers derivatized
the peptides with the fluorogenic dye naphthalene-2,3-
dicarboxaldehyde (NDA) [13–15], which is an analog of
the popular fluorogenic agent o-phthaldehyde (OPA)
[16]. The dye reacts in the presence of a nucleophilic agent
such as cyanide ion (CN-) or a thiol on the primary amine
of the N-terminal function of peptides to give stable
compounds which fluoresce with excitation of 420 to 440
nm [17]. Recently, two different analytical methods for
quantifying a model of opioid peptide (Tyr-D-Ala-Gly-
Phe-D-Leu) and two cyclic peptidic prodrugs in rat
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tion via NDA/CN derivatization and mass spectrome-
try with electrospray ionization (ESI) coupled to HPLC
[18]. These two methods present both advantages and
drawbacks; when LIF is employed, the enkephalins
have to be labeled, leading to less sensitive limits of
detection, while for MS, a specific internal standard is
needed for quantitation [18].
This paper describes our studies in the use of NDA
and an aminothiol as a derivatization process for both
fluorescence and MS quantitation of enkephalins. This
process would enable us to perform an HPLC separa-
tion with both LIF and mass spectrometry (MS) detec-
tion to optimize the identification and quantification of
enkephalins in biological samples. To use a common
separation for the two detection methods, the enkepha-
lins would have to be labeled to be fluorescent for LIF
detection and the labeled peptides must have an ioniz-
able site to provide ions for MS detection. We derivat-
ized enkephalin with NDA with a new nucleophilic
agent, N,N-dimethylaminoethanethiol (Me-AT), which
is easily ionizable due to its tertiary amine function [19].
A number of experiments are described and the results
are interpreted via molecular modeling and H/D ex-
change in mass spectrometry.
Experimental
Materials
Leu-Enk, N,N-dimethylaminoethanethiol, potassium cya-
nide (KCN), NDA, formic acids, boric acid, and sodium
tetraborate were purchased from Sigma-Aldrich Co. (St.
Quentin Fallavier, France). Solvents were obtained from
SDS (Aix en Provence, France) and deuterium oxide
was obtained from Eurisotop (Gif sur Yvette, France).
Peptide Labeling with NDA
Enkephalin samples were labeled by adding 720 L of
105 M peptide solution, 120 L of a 43 mM solution of
Figure 1. (a) Labeling reaction of enkephalins with NDA and
Me-AT. (b) Mass spectrum of leucine-enkephalin labeled with
NDA and Me-AT.N,N-dimethylaminoethanethiol or potassium cyanide,
120 L of borate buffer (pH 8.7), and 40 L of NDA (5
mM). Samples were filtered with 0.45 m uptidisc
Nylon filter (25 mm diameter; Waters, Guyaucourt,
France) and kept for 2 min at room temperature before
injection into the HPLC.
HPLC Analysis
HPLC analyses were run on a Dionex HPLC P680 pump
(Dionex, Voisin Le Bretonneux, France) with an LC
Packings Famos Autosampler (LC Packings, Dionex)
and a Picometrics ZetaLIF laser-induced fluorescence
detector equipped with a He-Cd 442 nm laser (Picomet-
rics, Toulouse, France). The sample was separated with
a Xbridge Shield RP18, 2.1  100 mm, 3.5 m column
(Waters Corporation, Milford, MA). A 375 m o.d. and
100 m i.d. fused silica capillary (Polymicro Technol-
ogy, Phoenix, AZ) was connected to the output of the
column. A window was burnt at 20 cm of the separa-
tion column to allow LIF detection. Eluents were
HPLC quality and filtered with a 45 m uptidisc
Nylon membrane (4.7 mm diameter (Interchim,
Montluçon, France). Flow rate was of 0.3 mL/min and
10 L of the sample were injected on the following
gradient: t 0 min to t 2 min, 80% H2O acidified with
0.1% formic acid and 20% acetonitrile, t  15 min 20%
H2O and 80% acetonitrile. Analyses were monitored by
Chromeleon software 6.60 (Dionex).
H/D exchange experiments were investigated using
the same conditions as HPLC except that water and
formic acid were substituted by deuterium oxide and
formic acid d2.
Mass Spectrometry
AWaters Q-TOf Ultima API mass spectrometer with an
electrospray ionization source (ESI) in positive mode
was directly coupled to the LIF detector. The capillary,
cone and rf lens potentials were set to 3 kV, 35 V, and 40
V, respectively. The source and desolvation tempera-
Figure 2. Comparative studies of equimolar solutions of native
Leu-Enk, Leu-Enk labeled with NDA/CN and Leu-Enk derivat-
ized with NDA/Me-AT in LC/LIF and LC/MS mode.ture were set to 100° and 120°C and the collision energy
1708 LACROIX ET AL. J Am Soc Mass Spectrom 2007, 18, 1706–1713was 10 eV in TOF-MS mode or 15 to 60 eV in TOF
MS/MS mode, and a 9.1 kV TOF potential was used.
Analyses were monitored with MassLynx 4.0 software
(Waters). To measure the exact mass, the spectrometer
was calibrated with H3PO4 adducts and an impurity
present in the eluent. In fact, the eluent was calibrated
with H3PO4 and then each peak corresponding to the
presumed labeled Leu-Enk was centered using the
exact mass of the impurity.
Molecular Modeling
Molecular modeling of the protonated labeled Leu-Enk
was investigated with Chem 3D software version 9.0
(ChemOffice Ultra 2005; Cambridge Software, Cam-
bridge, MA). Energy minimization was performed with
the semiempirical AM1 quantum mechanical calcula-
tions of the MOPAC server in the Chem 3D application,
with a RMS gradient of 0.100.
The calculated octanol/water partition coefficient
(ClogP) was obtained with the C-Log P server of the
ChemOffice Ultra 2005 application.
Figure 3. (a) Separation of labeled Met-Enk and Leu-Enk with
LIF detection at different concentration. (b) Total ion current (TIC)
of the two labeled enkephalins (5  106 mol/L) obtained with
mass spectrometric detection; tr 9.69 and 10.00 min correspond,
respectively, to labeled Met-Enk and Leu-Enk detectable by fluores-
cence and tr 8.63 and 9.04 min have not been observed with the LIF
detector but correspond to the masses of the labeled enkephalins.
Table 1. Results of labelled enkephalins with LIF detection and
LIF detection
Tr (min) LOD mol/L (S/N  3) Linearity
Met-Enk 9.87 0.09 y  2E  7x
Leu-Enk 9.55 0.10 y  2E  7xCalibration range was 0.1 mol/L-10 mol/L.The formation enthalpies (H°f), expressed in Kcal/
mol, were calculated with AM1 server for each confor-
mation. The hydrogen bonds were determined by mea-
suring the distance [in Angstrom (Å)] between the N–H
of amide bond and the C¢O of neighboring amide
function.
Results and Discussion
Labeling Studies of Enkephalins
Enkephalins react with NDA and N,N-dimethylamino-
ethanethiol (Me-AT) to form a fluorescent benzisoin-
dole derivative with a maximum absorbance at a wave-
length of 442 nm and a maximum emission at 530 nm.
The monoisotopic molecular mass of these derivatives
is 808.36 Da for Leu-Enk and 826.32 Da for Met-Enk,
both labeled with NDA and Me-AT. Using ESI, these
molecules give the parent ion (M  H) with a
specific fragmentation with a loss of a neutral com-
pound with a mass of 105.1 corresponding to the
mass of the aminothiol (Figure 1).
Comparative Studies of the Labeling NDA/KCN
and NDA/Me-AT
To verify if this new labeling method gives a more
ionizable molecule for mass detection, the NDA/
Me-AT labeled species (Leu-EnkMe-AT) was compared
with native Leu-Enk and NDA/CN labeled Leu-Enk
(Leu-Enk CN). Labeling conditions are the same for
Leu-Enk Me-At and Leu-Enk CN. Ten L of each
compound is injected three times. By comparing the ion
selected chromatograms (Figure 2), for 10 L of each
compounds injected, the new labeling method gives a
molecule that is more ionizable than native Leu-Enk
while the labeling of NDA/CN is poorly ionizable. On
the mass spectrum, the signal-to-noise ratios are 220 
18, 260  37, and 10  1 for NDA/Me-AT, native
Leu-Enk, and NDA/CN labeling, respectively. Even if
NDA/CN labeling gives a more fluorescent compound
than the enkephalin labeled with NDA/Me-AT, this
new labeling provides a good alternative to the combi-
nation of LIF and mass spectroscopy detection.
HPLC/LIF Experiments
The best separation of the enkephalins via HPLC using
a C18 column was obtained with a gradient as de-
etection
MS detection
R2 Tr 1 (min) m/z 1 Tr 2 (min) m/z 2
0.995 8.63 837.6&722.6 9.69 837.6
0.996 9.04 809.6&704.6 10.00 809.6MS d
 4,9
 1,9
o fra
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LIF detector was used; as its wavelength is compatible
with the maximum absorption of the labeled peptides.
Fluorescent peaks were obtained at retention times of
9.55 and 9.87 min for Met-Enk and Leu-Enk labeled
with NDA and Me-AT respectively (Figure 3a.) The
limit of detection (LOD) was 8.6  108 mol/L for
Met-Enk and 1.0  107 mol/L for Leu-Enk with a
signal-to-noise of 3 for each enkephalin. The calibration
curves were linear and are presented in Table 1.
Mass Spectrometry Detection
When the Met-Enk and Leu-Enk derivatives are ana-
lyzed via mass spectrometry, the chromatogram con-
tains four peaks for the m/z corresponding to the
peptides labeled with NDA and Me-AT (Figure 3b). For
both peptides, the second eluted peaks correspond to
the fluorescent compound detected with the LIF detec-
tor and the first peak presents another compound that
does not fluoresce.
The retention times and their corresponding masses
are summarized in Table 1 and the mass spectra for
Figure 4. TIC of Leu-Enk labeled with NDA an
tr 9.04 min spectrum with MH ion and its
chain, tr  10.00 min M  H parent ion and n
Figure 5. (a) Single ion monitoring (SIM) at m/z  809.5 of
labeled Leu-Enk, (b) MS/MS chromatogram at m/z  809.5,
collision energy of 30 eV.each peak were investigated. For Leu-Enk, the first-
eluted peak (9.04 min, nonfluorescent) provides an
exact mass at m/z  809.3719 with the specific fragmen-
tation at m/z  704.5 (loss of the aminothiol molecule).
The second peak (tr  10.00 min) was detected by
fluorescence and also provides a mass spectrum with
the parent ion at an exact mass at m/z  809.3753 but
without fragmentation at 704.5. The results for the
labeled Met-Enk were similar, so further experiments
were only performed on Leu-Enk (Figure 4).
The mass difference between these two m/z is 3.6
mDa; this is small enough to conclude that the peaks
correspond to the same molecule (the NDA-aminothiol-
labeled molecule) as they have the same mass (Figure 4).
MS/MS studies were investigated on each peak at
the mass m/z  809.5 at collision energies varying from
15 to 60 eV. At a retention time of 9.04 min, the fragment
corresponding to the loss of the aminothiol side chain
was observed until 40 eV of collision energy while no
fragmentation was obtained at any collision energies for
the peak at tr  10.00 min (Figure 5).
These experiments clearly indicate that if a labeled
peptide is injected, two peaks are observed on the
chromatogram from the mass spectrometer: the first
one that is eluted is not fluorescent but gives the specific
fragment corresponding to the loss of the aminothiol
side chain while the second eluted peak is fluorescent
but does not fragment even using MS/MS with 60 eV
collision energy.
From this data we suggest that there are two stable
conformations of the peptide. The acidic eluent ionizes
-AT and mass spectrum of each peak observed:
ent corresponding to the loss of aminothiol side
gmentation.
Table 2. Molecular modeling results for the different
conformations of labelled Leu-Enk
Conformationa ClogPa
H°f
kCal/mola
d (C¢O....H-N) Åa
(2-4)b (4-2)b (1-3)b
-turnc 4.0 1.98 2.16 2.29 —
310-Helix
d 6.3 18.6 — — 2.34
Extendedd 6.3 18.6 — — —
aCalculations are described in the experimental section.
b(X-Y) corresponds to the hydrogen bond between C¢O of the Xth
N-terminal amino acid and the N-H of the Yth N-terminal amino acid.
c d Me
fragmConformation obtained with H on the benzisoindole amine.
dConformation obtained with H on the aminothiol side chain.
1710 LACROIX ET AL. J Am Soc Mass Spectrom 2007, 18, 1706–1713the labeled compound on two different sites, which
modifies the spatial conformation of the two molecules.
This difference between these two stable conformations
could explain the difference of hydrophobicity and so the
two retention times were observed in mass spectrometry.
We note that a proton can settle on several basic sites
of the peptide; on the amine function on the benzisoin-
dole ring, on the amine that is on the nucleophilic side
chain, on the S atom of the thioether, or on the amide
function present in the Leu-Enk sequence. To verify
these hypotheses, molecular modeling studies and H/D
exchange experiments were performed.
Figure 6. Molecular modeling of labeled Leu-Enk with H fixed
on the benzisoindole amine (a) 2-D structure with its schematic
hydrogen bonds, (b) 3-D structure similar to the -turn conforma-
tion with its two hydrogen bonds.
Figure 7. Mechanism proposed to interpret th
chain and the loss of fluorescence.Molecular Modeling
The labeled peptides have four types of protonation
sites; the tertiary amine on the thioether side chain, the
aromatic amine included in the benzisoindole ring, or
the four amide functions corresponding to the peptidic
bonds of the enkephalin, and the thioether function.
Molecular modeling studies have been investigated on
each of the possible protonatable sites. A hydrophobicity
parameter ClogP was calculated (Table 2), and results
show that two kinds of conformations exist; one confor-
mation with ClogP close to 4 and the other around 6. As
amine functions are more basic and therefore more
easily protonatable than amide and thioether functions
[20], we focused on two possible sites; tertiary amine on
the aminothiol side chain and tertiary aromatic amine
included in the benzisoindole ring.
ClogP calculations of were performed to determine
the polarity of the molecules. It is well known that on a
reverse phase HPLC, molecules are separated according
to their polarities. If a specific molecule has a ClogP
lower than another compound, this compound would
be less retained on a C18 column than one that has a
higher ClogP, and a correlation of ClogP and the retention
time can be investigated.
The peak at tr  9.04 min represents Leu-Enk pro-
tonated on the amine included in the benzisoindole ring
because ClogP is 4.0, while the peak at tr  10.00 min
would be Leu-Enk protonated on the side chain for
which ClogP is 6.3 (Table 2). The position of the
protonation site involves the different hydrophobicity
correlated with both retention and the conformations.
Three dimensional studies of the labeled Leu-Enk
were investigated with respect to these two sites of
protonation. In the literature, three fundamental 3D
conformations have been characterized on these two
endogenous opioid peptides using a variety of different
methods such as FT-IR and NMR spectroscopy [21, 22],
molecular modeling [23–25], and mass spectrometry
[26, 27]. The first conformation was the extended con-
formation, which can be stabilized by intermolecular
hydrogen bonds. The second conformation is the -turn
folded form with two intramolecular hydrogen bonds;
the first between C¢ O (Tyr [1] and N–H (Gly [3]
and the second between C¢O (Phe [4] and N–H (Tyr [1].
The last conformation is the 310-helix structure with an
H bond between C  O (Tyr [1] and N–H (Gly [3] [21,
28, 29]. These conformations have been characterized in
aqueous solutions, DMSO, and a mixture of these two
solvents [21]. Since DMSO has a similar polarity (P) as
mentation with the loss of the aminothiol sidee frag
tructu
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0.62 E° Al2O3 for DMSO), the resulting conformations
are comparable with those characterized in the previous
conditions. In each case, the N-terminal function of
these peptides is not involved in the hydrogen bonds;
this observation leads us to suggest that the N primary
labeling peptides would not dramatically influence
conformations of the enkephalins.
When the proton is attached to the benzisoindole
aromatic amine, molecularmodeling gives a conformation
of Leu-Enk stabilized by two hydrogen bonds, the first
between C¢O (Phe [4] and N–H (Gly [2] and the second
between C¢O (Gly [2] and N–H (Phe [4]. T h e distances of
these bonds are listed in Table 2 with the formation
enthalpy calculations. We will call the previous confor-
mation “-turn” as shown in Figure 6. The literature
indicates that the fluorescence quantum yield of indoles
such as tryptophan is due to a hydrogen transfer from
the amino function of the chromophore, which involves
electron-deficient species in the cycle [30, 31]. In this case,
the loss of fluorescence can be due to the desocialization of
the electron when the proton is fixed on the amino
function included in the aromatic benzisoindole ring. In
fact, when this protonation occurs in the acidic eluant, the
molecule loses its aromaticity as there is an electron
deficiency that involves the fluorescence-quenching.
In addition, a fragmentation mechanism can be pro-
Figure 8. Molecular modeling of labeled Leu-En
structure with schema of its possible hydrogen
conformation with its hydrogen bond, (c) 3-D sposed. According to this correlation, a fragmentationcan occur when the proton is fixed on the ring (i.e.,
when Leu-Enk is folded). In this conformation, the
proton is closed to the sulfur atom of the aminothiol
side-chain (3.0 Å) and so a quick intramolecular
rearrangement can be possible with the loss of the
aminothiol (Figure 7).
When the proton is fixed on the amine function of
the aminothiol side chain, two conformations present
the lowest formation enthalpy (Table 2). The first one is
th H fixed on the aminothiol side-chain. (a) 2-D
d, (b) 3-D structure representing the 310-helix
re of the extended conformation.
Table 3. Results of the H/D exchanged on each conformation
with the average of the relative abundance of each mass and its
variations
m/z
Tr  9.04 min Tr  10.00 min
Relative
abundance %
CV
(n  3)
Relative
abundance %
CV
(n  3)
812 23.7 3.5 — —
813 57.9 6.8 6.6 1.3
814 100.0 — 27.2 2.7
815 73.7 5.7 69.7 3.5
816 32.0 3.0 100.0 —
817 14.5 2.3 74.6 4.6
818 — — 36.8 4.8
819 — — 13.2 1.3
820 — — 3.1 0.8k wi
bonCV  coefficient of variation.
Peaks’ heights are normalized prior to m/z 814 or 816.
1712 LACROIX ET AL. J Am Soc Mass Spectrom 2007, 18, 1706–1713stabilized by a hydrogen bond between C¢O (Tyr1] and
N–H (Gly3) like 310-helix. The second conformation is
similar to the extended form as it is linear without
intrachain interactions (Figure 8). Since the protonation
occurs on the side chain, the benzisoindole ring is not
affected and the compound can fluoresce. In addition,
the proton is too far from the thiol function to obtain an
intramolecular rearrangement such as in the previous
case, which can explain why there is no fragmentation
with the loss of the aminothiol side chain on the derivat-
ized peptide.
In summary, we suggest that the peak at tr  9.04
min is due to a -turn like form, which induced the easy
loss of the aminothiol side chain and the loss of fluo-
rescence, while the peak at tr  10.00 min could be
represented by an extended conformation or a 310-helix
form.
H/D Exchange Experiments
To confirm the above hypotheses and to determine the
conformation of the compound at tr  10.00 min, we
studied the H/D exchanges with labeled enkephalin.
Water and formic acid of the HPLC eluent were substi-
tuted by deuterium oxide and d2-formic acid so that all
labile hydrogen could be exchanged with deuterium. It
is well documented in the literature that the exchange
rate of a labile hydrogen depends on its solvent envi-
ronment [6, 26, 32, 33] (i.e., hydrogens involved in
hydrogen bonds or protected from the solvent are
less labile than hydrogens exposed to the solvent). If
the labeled Leu-Enk is eluted in the deuterated
eluent, it is possible to confirm that the difference
between the two peaks is due to spatial conforma-
Figure 9. Mass spectra of Leu-Enk labeled with NDA and
N,N-dimethylaminoethanethiol in deuterated eluent. (a) Mass
spectra corresponding to the fluorescent peak, (b) mass spectra
corresponding to the first peak whose fragments.
Table 4. Results of the quantitation of labelled Leu-Enk with m
Equation
Sta
dev
Folded labelled Leu-Enk y  34.298x  0.846 
Unfolded labelled Leu-Enk y  30.859x  0.051 Results were repeated three times at different day.tions and to determine them, as previously realized
on the native Leu-Enk [26].
H/D experiments were repeated three times and the
relative abundance of each peak on the mass spectrum
with their variation is summarized in Table 3. The mass
spectra show that mass difference between the two
peaks is slightly different; the first peak is predomi-
nantly at m/z  814.5, which corresponds to an ex-
change of the 5 atoms of deuterium on the 7 atoms,
which are exchangeable (Figure 9). Two hydrogens are
in particularly stable intramolecular bonds; this obser-
vation correlates with the -turn like conformation
where two hydrogen bonds are involved. Moreover, the
spectrum presents an ion at m/z 708.4, which corre-
sponds to the loss of the aminothiol containing one D;
the fragment contains 4 deuterium atoms. This result is
in accordance with the possible mechanism of fragmen-
tation. The second chromatographic peak occurs at m/z
816.5, which indicates that 7 atoms of deuterium are
exchanged, i.e., all the labile hydrogens have been
exchanged (Figure 9), so this second peak would corre-
spond to the extended conformation and not to a stable
310-helix conformation. This observation can be ex-
plained by the fact that 310-helix conformation has not
been determined in organic solvent [21].
Quantification of Leucine-Enkephalin
in Mass Spectrometry
As the aim of this method is to quantify Leu-Enk in
biological samples via mass spectrometry, the genera-
tion of a calibration curve for each conformation has
been investigated. Calibration curves obtained on the
two conformations are linear with acceptable standard
deviation on the slope (the standard deviation on the
intercept needs to be optimized). LOD with a signal-to-
noise of 3 was found to be 0.13 and 0.12 mol/L for the
folded and the unfolded conformation, respectively,
when 10 L samples were injected (Table 4). This ap-
proach for quantifying peptides could be applied even
with the phenomenon of the two conformations. However
the calibration can be improved by adding an internal
standard.
Conclusions
The mass spectrum of leucine-enkephalin labeled with
NDA and N,N-dimethylaminoethanethiol contains two
peaks when it is eluted via reverse phase HPLC while
only one peak is visible with fluorescence detection. An
etection on the two selected conformations
d
a
Standard
deviation b
LOD
mol/L R2
Standard
deviation R2
3.837 0.13 0,998 0.001
2.767 0.12 0,998 0.002ass d
ndar
iation
6.772
3.293
1713J Am Soc Mass Spectrom 2007, 18, 1706–1713 STUDIES BY MOLECULAR MODELING AND H/D EXCHANGEexplanation to this observation was proposed using
molecular modeling and mass spectrometry with H/D
exchange. These tools allowed us to demonstrate that
the difference between the two peaks is due to two
different spatial conformations, corresponding to two
different ionization sites; however we cannot demon-
strate if the conformations of the peptide moiety induce
an isomerization change of the benzisoindole moiety. In
addition, a mechanism has been proposed to explain
the in-source fragmentation involved in the nonfluores-
cent folded peptide.
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